PharmaForce named Lynn Eschenbacher as Chief Pharmacy and Strategy Officer. This move makes them more focused on running the modern 340B program and keeping things in order. Dr. Eschenbacher has a lot of experience in the changing world of 340B. As a result, the company reaffirms its commitment to providing health systems with high-performance results.
Dr. Eschenbacher has been in charge of pharmacy operations for more than 25 years. Before that, she was the Chief Pharmacy and Strategy Officer at Quva Pharma. She also worked as a senior executive at WakeMed Health & Hospitals and Ascension. She has also made important contributions to Duke University Hospital during her career. Her appointment comes at a time when the 340B market is going through a big change.
Right now, the 340B program management is under more regulatory scrutiny and has to deal with changing manufacturers. Health systems all over the country have less room for mistakes. A lot of companies still have trouble with broken systems and manual processes. Because of these problems, reports are often late and there isn’t much visibility. Because of this, the industry now needs operational accuracy and stability at the enterprise level.
Making operations more precise and AI more innovative
AI-driven oversight and real-time insights from PharmaForce meet these needs. The industry is moving away from reporting that only looks back. Instead, leaders focus on execution that is proactive and based on insights. This change encourages healthy growth and long-term financial success.
“340B has become a critical lever for health systems, but the expectations around execution have fundamentally changed,” said Rob Kill, CEO of PharmaForce. “This is no longer about retrospective reporting; it’s about real-time control, predictive insight, and operational discipline at scale. Lynn brings the exact combination of clinical credibility and enterprise leadership needed to help our clients meet that moment.”
Dr. Eschenbacher will now be in charge of the pharmacy strategy and clinical alignment. She wants to work closely with clients to keep an eye on their contract pharmacies. Also, she will help you deal with complicated market dynamics with more confidence. She is also very important in moving AI-driven strategies forward.
PharmaForce made its platform ready for businesses and to connect data. They offer unified, smart systems by getting rid of manual tools. This gives companies complete control and clarity over their operations.
“Health systems don’t need more complexity. They need the ability to deliver, with precision, on the promise 340B makes to patients,” said Dr. Eschenbacher. “As these programs grow more complex, legacy approaches are no longer enough. We’re taking a fundamentally different path by combining AI-driven insight, enterprise discipline, and deep operational expertise to ensure savings are not just generated, but reliably converted into care for the people who depend on them.”
Explore Health Tech Insiders for the latest medical innovations and reliable strategic insights driving the future of technology-driven healthcare transformation.
News Source: Businesswire.com
